Cannvas Continues to Increase Digital Assets to Drive Site Traffic, User Growth

Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF), a leading digital cannabis education and analytics company, is pleased to announce it continues to increase its digital assets, grow traffic to its digital cannabis education platform Cannvas.Me and drive new user sign-ups through the acquisition of nearly 1000 unique domains relating to health and cannabis education, cannabis data and analytics and pet healthcare through cannabis.

“The recent redesign of our corporate website alongside the acquisition of Cannvas.com as a centralized portal for our lineup of products and services underscores our commitment to strategically growing our business as we continue to increase our digital assets to drive site traffic and expand our user base as well as the reach of Cannvas.Me,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. “Cannvas plans to pursue digital assets aligned with our business goals and strengthen our portfolio of domains to ensure as many people as possible are exposed and interact with the Cannvas brand across Canada and the world.”

In the span of one calendar year, Cannvas has increased its digital assets by 240%, acquiring a total of 835 digital properties designed to increase user flow to Cannvas.Me and accumulate additional data to complement the information already actively analyzed by Cannvas. Multiple domains pointing back at Cannvas.Me also improves search engine optimization (SEO) and Cannvas is focused on ensuring its digital cannabis learning platform ranks high in global searches for cannabis education and related terms.

Since its launch in October 2018, Cannvas.Me has seen consistent month-to-month user growth of 30%, with a spectacular rise of 524% in March of this year. Attributed largely to its aggressive acquisition of strategic domains related to cannabis education, health care and data, Cannvas is now on track to have over 4 million unique users accessing its free and unbiased cannabis education in 2019, with over 50 million views of Cannvas articles and courses before year’s end. This puts Cannvas on track to have over 90% of countries around the world engaging with its content before the end of 2019.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: ir@cannvasmedtech.com or visit Cannvas.com

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF) for an Investor Presentation. 

Source: www.newswire.ca